TNFAIP8L2 Antibody, HRP conjugated

說明書

中文名稱：

TNFAIP8L2兔多克隆抗體, HRP偶聯(lián)
貨號：

CSB-PA754193LB01HU
規(guī)格：

￥880
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) TNFAIP8L2 Polyclonal antibody
Uniprot No.：

Q6P589
基因名：

TNFAIP8L2
別名：

AW610835 antibody; FLJ23467 antibody; Inflammation factor 20 antibody; Inflammation factor protein 20 antibody; TIPE2 antibody; TNF alpha-induced protein 8-like protein 2 antibody; TNFAIP8-like protein 2 antibody; TNFAIP8L2 antibody; TP8L2_HUMAN antibody; Tumor necrosis factor alpha induced protein 8 like 2 antibody; Tumor necrosis factor alpha-induced protein 8-like protein 2 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Tumor necrosis factor alpha-induced protein 8-like protein 2 protein (1-184AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

HRP
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
應用范圍：

ELISA
Protocols：

ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Acts as a negative regulator of innate and adaptive immunity by maintaining immune homeostasis. Negative regulator of Toll-like receptor and T-cell receptor function. Prevents hyperresponsiveness of the immune system and maintains immune homeostasis. Inhibits JUN/AP1 and NF-kappa-B activation. Promotes Fas-induced apoptosis.
基因功能參考文獻：
1. Our results demonstrated that TIPE2 is a novel tumor suppressor gene that inhibits GC growth may mediated via AKT and IkappaBalpha phosphorylated activation. PMID: 30157801
2. Low TIPE2 expression is associated with Gastric cancer. PMID: 30015980
3. The results of the present study indicated that TIPE2 acts as an inhibitor of hepatocellular carcinoma cell growth and aggressiveness, and promotes apoptosis, thus suggesting that TIPE2 may inhibit the metastasisassociated PI3K/AKT signaling cascade and may arrest the tumor cell cycle. PMID: 29568863
4. The expression of TIPE2 in THP1 cells may be upregulated by Poly I:C. PMID: 28849057
5. In conclusion, for the first time, we discovered that the Th2 milieu is able to upregulate TIPE2 expression in macrophages, which facilitates the change in macrophage phenotype and function and, in turn, potentially exaggerates eosinophilic inflammation and disease progression in chronic rhinosinusitis with nasal polyps. PMID: 28665518
6. TIPE2 may participate in T2DM by regulating TNF-alpha production PMID: 28626770
7. Our study identifies the molecular mechanisms underlying the interplay of TNF-alpha, TIPE2, and apoptosis during allograft rejection, and it suggests that both TNF-alpha and TIPE2 might be potential targets for the successfully grafted corneal endothelium. PMID: 29480366
8. TIPE2 inhibited the expression of asthma-related inflammatory factors in hyperstretched BEAS-2B cells by suppressing the Wnt/beta-catenin signaling pathway. PMID: 28188409
9. TIPE2 might be associated with immune clearance of patients with chronic hepatitis B. PMID: 28390195
10. TIPE2 could play important roles in maintaining the maternal-fetal tolerance and decreased TIPE2 expression in the decidua may be related to the development of missed abortion. PMID: 28851386
11. TIPE2 suppressed tumor invasiveness and angiogenesis in non-small cell lung cancer via inhibiting the activation of Rac1 and subsequently weakening its downstream effects, including F-actin polymerization and VEGF expression. PMID: 27556698
12. Further MD simulations confirmed the dynamic stability of these lipids in the TH domain. This computational analysis thus provides insight into the binding mode of phospholipids in the TH domain of the TIPE family of proteins. PMID: 27783229
13. the expression of TIPE2 protein could be a predictor of better prognosis for DLBCL. PMID: 27578327
14. Insufficient expression of TIPE2 might be involved in the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis. PMID: 26644386
15. data provided the first evidence that TIPE2 inhibits gastric cancer cell migration, invasion and metastasis very probably via reversal of EMT, revealing that TIPE2 may be a novel therapeutic target for human gastric cancer EMT and metastasis. PMID: 28186089
16. Authors demonstrated that TIPE2 overexpression may suppress proliferation, migration, and invasion in prostate cancer cells by inhibiting the PI3K/Akt signaling pathway. PMID: 27712587
17. TIPE2 suppressed breast cancer tumorigenesis, growth and metastasis possibly via regulation of the AKT and p38 signaling pathways. PMID: 27779698
18. these data suggest that TIPE2 overexpression inhibited hypoxia-induced Wnt/beta-catenin pathway activation and EMT in glioma cells. PMID: 27656836
19. this study shows that TIPE2 contributes to the pathogenesis of ankylosing spondylitis PMID: 27816498
20. TIPE2 expression was significantly decreased in human breast cancer tissue and cell lines. Overexpression of TIPE2 inhibited the proliferation in vitro and tumor xenograft growth in vivo. TIPE2 also inhibited the migration/invasion of breast cancer cells through preventing the epithelial-to-mesenchymal transition (EMT) phenotype. PMID: 28081733
21. Low expression of TIPE2 is associated with hepatocellular carcinogenesis. PMID: 27696294
22. our data suggest a previously unappreciated role of TIPE2 in the crosstalk between skin SCC and TAMs and highlight TIPE2 as a promising novel target for skin SCC treatment. PMID: 26577853
23. Results provide evidence that TIPE2 acts as an inhibitor of gastric cancer cell growth and triggers an IRF4-associated signaling cascade that promotes p27 expression and restores control of cell proliferation. PMID: 26781452
24. The TIPE2-elicited antimetastatic effect in gastric cancer was closely associated with the inhibition of AKT signaling and enhancement of GSK3b activity followed by the degradation and decreased translocation to nucleus of b-catenin PMID: 26530498
25. TIPE2 promoted lung cancer cell apoptosis through affecting apoptosis-related molecules caspase-3, caspase-9, Bcl-2 and Bax, possibly via regulating P38 and Akt pathways. PMID: 25946186
26. Tumor necrosis factor-alpha-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation PMID: 25536447
27. TIPE2 mRNA showed sensitivity of 74.63%, specificity of 90.24%, positive predictive value of 92.5%, and negative predictive value of 67.3% for predicting 3-month mortality in Acute-on-Chronic Hepatitis B Liver Failure. PMID: 26426653
28. These results strongly suggest that TIPE2 plays an important role in shifting L-arginase metabolism from production of NO to urea, during host inflammatory response. PMID: 24806446
29. Both TNF-alpha and TIPE2 might be potential targets for the treatment of hepatocellular carcinoma metastasis. PMID: 25339267
30. TIPE2 might serve as a tumor suppressor in non-small cell lung cancer progression. PMID: 25542151
31. TIPE2 can inhibit caspase-8 activity in colon cancer cells. TIPE2 can regulate TLR4 inflammatory effect and inhibit further amplification of cascade reaction via caspase-8. PMID: 24934366
32. TIPE2 plays an important role in regulating hepatitis B virus-specific CD8(+) T cell functions in patients with hepatitis B. PMID: 25499447
33. Human TIPE2 is an endogenous inhibitor of Rac1 in hepatocellular carcinoma (HCC) by which it attenuates invasion and metastasis of HCC. PMID: 24274578
34. TIPE2 mRNA and protein expression were decreased in children with asthma compared with healthy controls. PMID: 24107080
35. Letter: detection of TIPE2 in the blood samples may be used as one of the diagnosis molecular markers in clinical monitoring kidney chronic rejection. PMID: 23009108
36. TIPE2 is an inhibitor of both inflammation and cancer, and a potential drug target for inflammatory and neoplastic diseases. PMID: 22326055
37. The unique expressional profile of human TIPE2 suggests new functions beyond controlling innate and adaptive immunity. PMID: 21459448
38. These results indicate that TIPE2 plays an important role in taming Hepatitis B virus-induced hepatic inflammation. PMID: 21466895
39. High levels of TIPE2 were detected in monocyte/macrophage derived cell lines and ovarian adenocarcinoma cells, but not detectable or weakly expressed in most human carcinoma cell lines. PMID: 20663561
顯示更多

收起更多
蛋白家族：

TNFAIP8 family, TNFAIP8L2 subfamily
數(shù)據(jù)庫鏈接：

HGNC: 26277

OMIM: 612112

KEGG: hsa:79626

STRING: 9606.ENSP00000357906

UniGene: Hs.432360

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human